Is Illumina Stock a Good Investment?

Illumina Investment Advice

ILMN

To provide specific investment advice or recommendations on Illumina stock, we recommend investors consider the following general factors when evaluating Illumina. This will help you to make an informed decision on whether to include Illumina in one of your diversified portfolios:

Examine Illumina's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Illumina's leadership team and their track record. Good management can help Illumina navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Life Sciences Tools & Services space and any emerging trends that could impact Illumina's business and its evolving consumer preferences.
Compare Illumina's performance and market position to its competitors. Analyze how Illumina is positioned in terms of product offerings, innovation, and market share.
Check if Illumina pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Illumina's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in Illumina stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Illumina is a good investment.

Sell

Buy

Hold

Macroaxis provides investment recommendation on Illumina to complement and cross-verify current analyst consensus on Illumina. Our trade recommendations engine determines the entity's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Illumina is not overpriced, please check out all Illumina fundamentals, including its current ratio, total asset, and the relationship between the net income and price to earnings to growth . Given that Illumina has a price to earning of 49.12 X, we strongly advise you to confirm Illumina market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Market Performance	Very Weak	Details
Volatility	Very steady	Details
Hype Condition	Stale	Details
Current Valuation	Overvalued	Details
Odds Of Distress	Low	Details
Economic Sensitivity	Slowly supersedes the market	Details
Investor Sentiment	Interested	Details
Analyst Consensus	Buy	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Unavailable	Details

Examine Illumina Stock

Researching Illumina's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 95.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.63. Illumina recorded a loss per share of 9.98. The entity had not issued any dividends in recent years. The firm had 1028:1000 split on the 25th of June 2024.

To determine if Illumina is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Illumina's research are outlined below:

	Illumina currently holds 2.26 B in liabilities with Debt to Equity (D/E) ratio of 0.38, which is about average as compared to similar companies. Illumina has a current ratio of 0.91, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Illumina's use of debt, we should always consider it together with its cash and equity.
	The entity reported the previous year's revenue of 4.5 B. Net Loss for the year was (1.16 B) with profit before overhead, payroll, taxes, and interest of 3.15 B.
	Over 95.0% of Illumina shares are owned by institutional investors
	Latest headline from gurufocus.com: Myriad Genetics Announces Incorporation of its Proprietary HRD p

Illumina Quarterly Accounts Payable

191 Million

Illumina uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Illumina. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Illumina's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	8th of February 2024 Upcoming Quarterly Report	View
	23rd of April 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	8th of February 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

Earnings surprises can significantly impact Illumina's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Illumina's investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2005-10-24	2005-09-30	-0.02	-0.01	0.01	50
2005-07-26	2005-06-30	-0.03	-0.04	-0.01	33
2004-07-14	2004-06-30	-0.06	-0.05	0.01	16
2001-11-08	2001-09-30	-0.1	-0.09	0.01	10
2001-04-25	2001-03-31	-0.09	-0.08	0.01	11
2000-10-12	2000-09-30	-0.1	-0.09	0.01	10
2006-04-18	2006-03-31	0.01	-0.0013	-0.0113	113
2010-04-28	2010-03-31	0.19	0.21	0.02	10

Know Illumina's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Illumina is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Illumina backward and forwards among themselves. Illumina's institutional investor refers to the entity that pools money to purchase Illumina's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

		Shares
Primecap Management Company	2024-09-30	2.5 M
Alliancebernstein L.p.	2024-06-30	2.5 M
Corvex Management Lp	2024-06-30	2.3 M
Norges Bank	2024-06-30	2.1 M
Nuveen Asset Management, Llc	2024-06-30	1.9 M
Bank Of America Corp	2024-06-30	1.6 M
Legal & General Group Plc	2024-06-30	1.6 M
Hhg Plc	2024-06-30	1.5 M
Millennium Management Llc	2024-06-30	1.5 M
Blackrock Inc	2024-06-30	18.1 M
Vanguard Group Inc	2024-09-30	15.9 M

Note, although Illumina's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Illumina's market capitalization trends

The company currently falls under 'Large-Cap' category with a current market capitalization of 20.88 B.

Market Cap

1.61 Billion

Illumina's profitablity analysis

	Last Reported	Projected for Next Year
Return On Tangible Assets	(0.25)	(0.24)
Return On Capital Employed	(0.13)	(0.12)
Return On Assets	(0.11)	(0.11)
Return On Equity	(0.20)	(0.19)

The company has Profit Margin (PM) of (0.36) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.24 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.24.

Determining Illumina's profitability involves analyzing its financial statements and using various financial metrics to determine if Illumina is a good buy. For example, gross profit margin measures Illumina's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Illumina's profitability and make more informed investment decisions.

Illumina's Earnings Breakdown by Geography

Evaluate Illumina's management efficiency

Illumina has return on total asset (ROA) of 0.0262 % which means that it generated a profit of $0.0262 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3951) %, meaning that it created substantial loss on money invested by shareholders. Illumina's management efficiency ratios could be used to measure how well Illumina manages its routine affairs as well as how well it operates its assets and liabilities. As of the 21st of November 2024, Return On Tangible Assets is likely to grow to -0.24. In addition to that, Return On Capital Employed is likely to grow to -0.12. At this time, Illumina's Debt To Assets are very stable compared to the past year. As of the 21st of November 2024, Fixed Asset Turnover is likely to grow to 3.35, while Non Currrent Assets Other are likely to drop about 123.4 M.

	Last Reported	Projected for Next Year
Book Value Per Share	36.36	38.18
Tangible Book Value Per Share	1.31	1.24
Enterprise Value Over EBITDA	(37.16)	(35.30)
Price Book Value Ratio	3.72	5.32
Enterprise Value Multiple	(37.16)	(35.30)
Price Fair Value	3.72	5.32
Enterprise Value	1.5 B	1.6 B

Illumina has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.

Beta

1.131

Basic technical analysis of Illumina Stock

As of the 21st of November, Illumina retains the Risk Adjusted Performance of 0.0115, market risk adjusted performance of 0.0167, and Downside Deviation of 2.09. Illumina technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Illumina's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Illumina insiders, such as employees or executives, is commonly permitted as long as it does not rely on Illumina's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Illumina insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

		Jacob Thaysen over a month ago Disposition of 914 shares by Jacob Thaysen of Illumina at 140.66 subject to Rule 16b-3
		Jacob Thaysen over a month ago Acquisition by Jacob Thaysen of 7426 shares of Illumina subject to Rule 16b-3
		Ullem Scott B. over six months ago Acquisition by Ullem Scott B. of 163 shares of Illumina at 137.682 subject to Rule 16b-3
		Roy Whitfield over a year ago Exercise or conversion by Roy Whitfield of 800 shares of Illumina subject to Rule 16b-3

Illumina's Outstanding Corporate Bonds

Illumina issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Illumina uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Illumina bonds can be classified according to their maturity, which is the date when Illumina has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	ILMN 255 23 MAR 31 Corp Bond US452327AM11	View
	ILMN 58 12 DEC 25 Corp Bond US452327AN93	View
	ILMN 575 13 DEC 27 Corp Bond US452327AP42	View
	ILLUMINATE BUYER LLC Corp Bond US45232TAA97	View
	ILLINOIS TOOL WKS Corp Bond US452308AR01	View
	ILLINOIS TOOL WKS Corp Bond US452308AQ28	View
	ILLINOIS TOOL WKS Corp Bond US452308AX78	View

View All Illumina Corporate Bonds

Understand Illumina's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Illumina's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	0.0115
	Market Risk Adjusted Performance	0.0167
	Mean Deviation	1.71
	Semi Deviation	2.05
	Downside Deviation	2.09
	Coefficient Of Variation	15478.56
	Standard Deviation	2.21
	Variance	4.87
	Information Ratio	(0.04)
	Jensen Alpha	(0.05)
	Total Risk Alpha	(0.25)
	Sortino Ratio	(0.04)
	Treynor Ratio	0.0067
	Maximum Drawdown	12.84
	Value At Risk	(2.69)
	Potential Upside	3.72
	Downside Variance	4.35
	Semi Variance	4.2
	Expected Short fall	(1.72)
	Skewness	0.6326
	Kurtosis	1.45

	Risk Adjusted Performance	0.0115
	Market Risk Adjusted Performance	0.0167
	Mean Deviation	1.71
	Semi Deviation	2.05
	Downside Deviation	2.09
	Coefficient Of Variation	15478.56
	Standard Deviation	2.21
	Variance	4.87
	Information Ratio	(0.04)
	Jensen Alpha	(0.05)
	Total Risk Alpha	(0.25)
	Sortino Ratio	(0.04)
	Treynor Ratio	0.0067
	Maximum Drawdown	12.84
	Value At Risk	(2.69)
	Potential Upside	3.72
	Downside Variance	4.35
	Semi Variance	4.2
	Expected Short fall	(1.72)
	Skewness	0.6326
	Kurtosis	1.45

Consider Illumina's intraday indicators

Illumina intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Illumina stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	101497.0
	Daily Balance Of Power	0.75
	Rate Of Daily Change	1.04
	Day Median Price	133.65
	Day Typical Price	134.76
	Price Action Indicator	6.0
	Period Momentum Indicator	5.31
	Relative Strength Index	46.88

Illumina Corporate Filings

13A	12th of November 2024 An amended filing to the original Schedule 13G	View Verify
F4	7th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities	View Verify
10Q	6th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations	View Verify
F3	15th of October 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock	View Verify

Illumina time-series forecasting models is one of many Illumina's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Illumina's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Illumina Stock media impact

Far too much social signal, news, headlines, and media speculation about Illumina that are available to investors today. That information is available publicly through Illumina media outlets and privately through word of mouth or via Illumina internal channels. However, regardless of the origin, that massive amount of Illumina data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of Illumina news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Illumina relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Illumina's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Illumina alpha.

Illumina Historical Investor Sentiment

Investor biases related to Illumina's public news can be used to forecast risks associated with an investment in Illumina. The trend in average sentiment can be used to explain how an investor holding Illumina can time the market purely based on public headlines and social activities around Illumina. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Illumina's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Illumina and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Illumina news discussions. The higher the estimate score, the more favorable the investor's outlook on Illumina.

Illumina Corporate Management

Steven Hoffman	Segment Sequencing	Profile
Pat Leckman	Interim Officer	Profile
Ankur Dhingra	Chief Officer	Profile
Nicole Berry	Head RegionAmericas	Profile

When determining whether Illumina offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Illumina's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Illumina Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Illumina Stock: